Lucid Diagnostics Inc
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +0.6% | -20.3% | -54.3% | -6.1% | +3.3% | -0.5% | +0.5% | -0.9% | +194,800.0% | -99.9% | +0.9% | – | |
| – | -23.1% | -3.2% | +29.1% | +2.1% | -4.6% | -12.0% | +11.1% | +0.7% | +199,018.8% | -99.9% | +20.6% | – | |
| – | -140.0% | – | – | – | – | -242.6% | – | – | – | – | – | – | |
| – | +1,150.0% | -78.9% | -100.0% | – | -26.0% | -64.1% | -73.1% | +12.0% | +82.1% | +321.6% | -90.2% | – | |
| – | +1,150.0% | -78.9% | – | – | -26.0% | -64.1% | -73.1% | +12.0% | +82.1% | +321.6% | -90.2% | – | |
| – | – | +28.4% | – | – | – | – | -100.0% | – | -51.8% | +60.3% | +0.0% | – | |
| – | – | – | – | – | – | -98.0% | -100.0% | – | – | – | – | – | |
| – | +1,718.2% | +270.4% | -37.2% | -99.2% | +19,047.9% | -14.2% | +6.6% | +64.8% | -100.0% | +274,250.0% | +207.0% | – | |
| – | – | – | -97.4% | -7,007.9% | – | -63.4% | +104.3% | +175.4% | -177.9% | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 7, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.